IL6R and COVID-19: This post hoc analysis of plasma lipid samples from hospitalized patients with severe-to-critical COVID-19 shows that a marked HDL-C depression is dependent on disease severity and, overall, is not responsive to anti-inflammatory intervention with an IL-6R monoclonal antibody.